News | December 15, 2021
NATCO Pharma to acquire Dash Pharmaceuticals
The cash consideration for the acquisition is US$ 18 million.
The cash consideration for the acquisition is US$ 18 million.
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
Revlimid is a blood cancer drug with sales of US $ 12.1 billion in 2020
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
Subscribe To Our Newsletter & Stay Updated
